Your browser doesn't support javascript.
loading
White matter diffusion estimates in obsessive-compulsive disorder across 1653 individuals: machine learning findings from the ENIGMA OCD Working Group.
Kim, Bo-Gyeom; Kim, Gakyung; Abe, Yoshinari; Alonso, Pino; Ameis, Stephanie; Anticevic, Alan; Arnold, Paul D; Balachander, Srinivas; Banaj, Nerisa; Bargalló, Nuria; Batistuzzo, Marcelo C; Benedetti, Francesco; Bertolín, Sara; Beucke, Jan Carl; Bollettini, Irene; Brem, Silvia; Brennan, Brian P; Buitelaar, Jan K; Calvo, Rosa; Castelo-Branco, Miguel; Cheng, Yuqi; Chhatkuli, Ritu Bhusal; Ciullo, Valentina; Coelho, Ana; Couto, Beatriz; Dallaspezia, Sara; Ely, Benjamin A; Ferreira, Sónia; Fontaine, Martine; Fouche, Jean-Paul; Grazioplene, Rachael; Gruner, Patricia; Hagen, Kristen; Hansen, Bjarne; Hanna, Gregory L; Hirano, Yoshiyuki; Höxter, Marcelo Q; Hough, Morgan; Hu, Hao; Huyser, Chaim; Ikuta, Toshikazu; Jahanshad, Neda; James, Anthony; Jaspers-Fayer, Fern; Kasprzak, Selina; Kathmann, Norbert; Kaufmann, Christian; Kim, Minah; Koch, Kathrin; Kvale, Gerd.
Afiliação
  • Kim BG; Department of Psychology, College of Social Sciences, Seoul National University, Seoul, Republic of Korea.
  • Kim G; Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea.
  • Abe Y; Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Department of Psychiatry, Kyoto City, Japan.
  • Alonso P; Bellvitge Biomedical Research Insitute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain.
  • Ameis S; CIBER of Mental Health (CIBERSAM), Carlos III Health Institute, Madrid, Spain.
  • Anticevic A; Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.
  • Arnold PD; The Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Balachander S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Banaj N; Program in Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Bargalló N; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, 06510, USA.
  • Batistuzzo MC; The Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Benedetti F; Departments of Psychiatry and Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Bertolín S; OCD clinic, Department of Psychiatry, National Institute of Mental Health And Neurosciences (NIMHANS), Bangalore, India.
  • Beucke JC; Laboratory of Neuropsychiatry, Department of Clinical and Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Bollettini I; Center of Image Diagnostic, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Brem S; Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Brennan BP; Departamento e Instituto de Psiquiatria do Hospital das Clinicas, IPQ HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
  • Buitelaar JK; Department of Methods and Techniques in Psychology, Pontifical Catholic University, São Paulo, SP, Brazil.
  • Calvo R; Vita-Salute San Raffaele University, Milano, Italy.
  • Castelo-Branco M; Psychiatry & Clinical Psychobiology, Division of Neuroscience, IRCCS Scientific Institute Ospedale San Raffaele, Milano, Italy.
  • Cheng Y; CIBER of Mental Health (CIBERSAM), Carlos III Health Institute, Madrid, Spain.
  • Chhatkuli RB; Bellvitge Biomedical Research Institute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain.
  • Ciullo V; Department of Psychology, Humboldt-Universitat zu Berlin, Berlin, Germany.
  • Coelho A; Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm, Sweden.
  • Couto B; Department of Medical Psychology, Medical School Hamburg, Hamburg, Germany.
  • Dallaspezia S; Psychiatry & Clinical Psychobiology, Division of Neuroscience, IRCCS Scientific Institute Ospedale San Raffaele, Milano, Italy.
  • Ely BA; Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.
  • Ferreira S; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
  • Fontaine M; McLean Hospital, Belmont, MA, USA.
  • Fouche JP; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Grazioplene R; Radboudumc, Department of Cognitive Neuroscience, Nijmegen, The Netherlands.
  • Gruner P; Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The Netherlands.
  • Hagen K; CIBER of Mental Health (CIBERSAM), Carlos III Health Institute, Madrid, Spain.
  • Hansen B; Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain.
  • Hanna GL; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Hirano Y; Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Höxter MQ; Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), University of Coimbra, 3000-548, Coimbra, Portugal.
  • Hough M; Institute for Nuclear Sciences Applied to Health (ICNAS), University of Coimbra, 3000-548, Coimbra, Portugal.
  • Hu H; Faculty of Medicine, University of Coimbra, 3000-548, Coimbra, Portugal.
  • Huyser C; Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Ikuta T; Research Center for Child Mental Development, Chiba University, Chiba, Japan.
  • Jahanshad N; United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University, Chiba University and University of Fukui, Suita, Japan.
  • James A; Laboratory of Neuropsychiatry, Department of Clinical and Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Jaspers-Fayer F; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • Kasprzak S; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimaraes, Portugal.
  • Kathmann N; Clinical Academic Center - Braga, Braga, Portugal.
  • Kaufmann C; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • Kim M; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimaraes, Portugal.
  • Koch K; Clinical Academic Center - Braga, Braga, Portugal.
  • Kvale G; Psychiatry & Clinical Psychobiology Unit, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.
Mol Psychiatry ; 29(4): 1063-1074, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38326559
ABSTRACT
White matter pathways, typically studied with diffusion tensor imaging (DTI), have been implicated in the neurobiology of obsessive-compulsive disorder (OCD). However, due to limited sample sizes and the predominance of single-site studies, the generalizability of OCD classification based on diffusion white matter estimates remains unclear. Here, we tested classification accuracy using the largest OCD DTI dataset to date, involving 1336 adult participants (690 OCD patients and 646 healthy controls) and 317 pediatric participants (175 OCD patients and 142 healthy controls) from 18 international sites within the ENIGMA OCD Working Group. We used an automatic machine learning pipeline (with feature engineering and selection, and model optimization) and examined the cross-site generalizability of the OCD classification models using leave-one-site-out cross-validation. Our models showed low-to-moderate accuracy in classifying (1) "OCD vs. healthy controls" (Adults, receiver operator characteristic-area under the curve = 57.19 ± 3.47 in the replication set; Children, 59.8 ± 7.39), (2) "unmedicated OCD vs. healthy controls" (Adults, 62.67 ± 3.84; Children, 48.51 ± 10.14), and (3) "medicated OCD vs. unmedicated OCD" (Adults, 76.72 ± 3.97; Children, 72.45 ± 8.87). There was significant site variability in model performance (cross-validated ROC AUC ranges 51.6-79.1 in adults; 35.9-63.2 in children). Machine learning interpretation showed that diffusivity measures of the corpus callosum, internal capsule, and posterior thalamic radiation contributed to the classification of OCD from HC. The classification performance appeared greater than the model trained on grey matter morphometry in the prior ENIGMA OCD study (our study includes subsamples from the morphometry study). Taken together, this study points to the meaningful multivariate patterns of white matter features relevant to the neurobiology of OCD, but with low-to-moderate classification accuracy. The OCD classification performance may be constrained by site variability and medication effects on the white matter integrity, indicating room for improvement for future research.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imagem de Tensor de Difusão / Substância Branca / Aprendizado de Máquina / Transtorno Obsessivo-Compulsivo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imagem de Tensor de Difusão / Substância Branca / Aprendizado de Máquina / Transtorno Obsessivo-Compulsivo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2024 Tipo de documento: Article